Detalhe da pesquisa
1.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
2.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732648
3.
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine
; 41(13): 2253-2260, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868877
4.
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine
; 41(11): 1875-1884, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781334
5.
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents.
Hum Vaccin Immunother
; 19(1): 2206359, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226504
6.
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Lancet Infect Dis
; 22(7): 990-1001, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447085
7.
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2-9 Years of Age: A Phase III, Randomized Study.
Pediatr Infect Dis J
; 39(10): 955-960, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852352
8.
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
J Pediatric Infect Dis Soc
; 9(2): 194-201, 2020 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849175
9.
Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
Hum Vaccin Immunother
; 13(7): 1516-1522, 2017 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481690
10.
Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children.
Pediatr Infect Dis J
; 35(6): 662-72, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26928521
11.
Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial.
Pediatr Infect Dis J
; 34(11): 1236-43, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26237742
12.
Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™.
Vaccine
; 33(7): 924-32, 2015 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25305567
13.
Comparison of recovery from postoperative pain utilizing two sling techniques.
Can J Urol
; 10(1): 1759-63, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12625855
14.
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.
J Pediatric Infect Dis Soc
; 3(1): 33-42, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567843
15.
The changing epidemiology of meningococcal disease in North America 1945-2010.
Hum Vaccin Immunother
; 9(1): 162-71, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108355
16.
Reply letter.
Hum Vaccin Immunother
; 9(6): 1325, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23563056